Long-Term Survival in Differentiated Thyroid Cancer Is Worse After Low-Activity Initial Post-Surgical 131I Therapy in Both High- and Low-Risk Patients
FA Verburg, U Mäder, C Reiners… - The Journal of Clinical …, 2014 - academic.oup.com
Context: Recent trial results have revived interest in low-activity initial 131I therapy (RIT) of
differentiated thyroid cancer (DTC). Objective: This study sought to compare different initial …
differentiated thyroid cancer (DTC). Objective: This study sought to compare different initial …
Low-dose radioiodine therapy for patients with intermediate-to high-risk differentiated thyroid cancer
K Abe, U Ishizaki, T Ono, K Horiuchi, K Kanaya… - Annals of Nuclear …, 2020 - Springer
Objective The efficacy of low-dose radioiodine therapy (RIT) for intermediate-risk or high-risk
differentiated thyroid cancer (DTC) patients is controversial. Because of the country's …
differentiated thyroid cancer (DTC) patients is controversial. Because of the country's …
No Adverse Affect in Clinical Outcome Using Low Preablation Diagnostic 131I Activity in Differentiated Thyroid Cancer: Refuting Thyroid-Stunning Effect
BK Yap, B Murby - The Journal of Clinical Endocrinology & …, 2014 - academic.oup.com
Context: Published studies of thyroid stunning due to preablation 131I scanning in the
treatment of differentiated thyroid cancer after thyroidectomy had shown inconsistent clinical …
treatment of differentiated thyroid cancer after thyroidectomy had shown inconsistent clinical …
Outcome of patients with differentiated thyroid cancer treated with 131-iodine on the basis of a detectable serum thyroglobulin level after initial treatment
M Klain, L Pace, E Zampella, T Mannarino… - Frontiers in …, 2019 - frontiersin.org
Background: In patients with differentiated thyroid cancer (DTC) and raising serum
thyroglobulin (Tg) after total or near-total thyroidectomy and 131I remnant ablation an …
thyroglobulin (Tg) after total or near-total thyroidectomy and 131I remnant ablation an …
Multiple-factor analysis of the first radioactive iodine therapy in post-operative patients with differentiated thyroid cancer for achieving a disease-free status
N Liu, Z Meng, Q Jia, J Tan, G Zhang, W Zheng… - Scientific reports, 2016 - nature.com
Abstract 131I treatment is an important management method for patients with differentiated
thyroid cancer (DTC). Unsuccessful 131I ablation drastically affects the prognosis of the …
thyroid cancer (DTC). Unsuccessful 131I ablation drastically affects the prognosis of the …
Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single …
J Brierley, R Tsang, T Panzarella… - Clinical …, 2005 - Wiley Online Library
Objectives To assess the prognostic factors and the role of radioactive iodine (RAI) and
external beam radiotherapy (RT) in patients with differentiated thyroid cancer. Design A …
external beam radiotherapy (RT) in patients with differentiated thyroid cancer. Design A …
Delayed initial radioiodine therapy related to incomplete response in low‐to intermediate‐risk differentiated thyroid cancer
H Li, Y Zhang, C Wang, X Zhang, X Li… - Clinical …, 2018 - Wiley Online Library
Objective Whether the initiating time of radioiodine (RAI) therapy will affect the clinical
outcome in differentiated thyroid cancer (DTC) remains controversial. The objective of this …
outcome in differentiated thyroid cancer (DTC) remains controversial. The objective of this …
Clinical outcomes of low-dose and high-dose postoperative radioiodine therapy in patients with intermediate-risk differentiated thyroid cancer
JH Jeong, EJ Kong, SY Jeong, SW Lee… - Nuclear medicine …, 2017 - journals.lww.com
Purpose Recent studies have suggested that a low dose (LD) of radioiodine (RAI) is
sufficient to treat differentiated thyroid cancer (DTC) even in patients with intermediate risk …
sufficient to treat differentiated thyroid cancer (DTC) even in patients with intermediate risk …
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients
MG Castagna, G Cevenini… - European journal of …, 2013 - academic.oup.com
Background In differentiated thyroid cancer (DTC) patients at intermediate risk of
recurrences, no evidences are provided regarding the optimal radioactive iodine (RAI) …
recurrences, no evidences are provided regarding the optimal radioactive iodine (RAI) …
The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinoma
ED Thies, K Tanase, U Maeder, M Luster… - European journal of …, 2014 - Springer
Purpose To assess the risk of differentiated thyroid cancer (DTC) recurrence, DTC-related
mortality and life expectancy in relation to the number of courses of 131 I therapy (RIT) and …
mortality and life expectancy in relation to the number of courses of 131 I therapy (RIT) and …